The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
Open accessAbstract
Background and Aims: The risk factors of cholelithiasis have not been clearly identified, especially for total cholesterol. Here, we try to identify these causal risk factors. Approach and Results: We obtained genetic variants associated with the exposures at the genome‐wide significance (p < 5 × 10−8) level from corresponding genome‐wide association studies. Summary‐level statistical data for cholelithiasis were obtained from FinnGen and UK Biobank (UKB) consortia. Both univariable and multivariable Mendelian randomization (MR) analyses were conducted to identify causal risk factors of cholelithiasis. Results from FinnGen and UKB were combined using the fixed‐effect model. In FinnGen, the odds of cholelithiasis increased per 1‐SD increase of body mass index (BMI) (OR = 1.631, p = 2.16 × 10−7), together with body fat percentage (OR = 2.108, p = 4.56 × 10−3) and fasting insulin (OR = 2.340, p = 9.09 × 10−3). The odds of cholelithiasis would also increase with lowering of total cholesterol (OR = 0.789, p = 8.34 × 10−5) and low‐density lipoprotein–cholesterol (LDL‐C) (OR = 0.792, p = 2.45 × 10−4). However, LDL‐C was not significant in multivariable MR. In UKB, the results of BMI, body fat percentage, total cholesterol, and LDL‐C were replicated. In meta‐analysis, the liability to type 2 diabetes mellitus and smoking could also increase the risk of cholelithiasis. Moreover, there were no associations with other predominant risk factors. Conclusions: Our MR study corroborated the risk factors of cholelithiasis from previous MR studies. Furthermore, lower total cholesterol level could be an independent risk factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verbanck, M., Chen, C.-Y., Neale, B., & Do, R. (2018) · Nature Genetics · doi:10.1038/s41588-018-0099-7 · Cited by 8,591
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess, S., & Thompson, S. G. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0255-x · Cited by 4,571
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationWiller (2013) · doi:10.1038/ng.2797 · Cited by 2,983
23andMe Research Team, Liu, M., Psychiatry, H. A.-I., Jiang, Y., Wedow, R., Li, Y., Brazel, D. M., Chen, F., Datta, G., Davila-Velderrain, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0307-5 · Cited by 1,896
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
New genetic loci link adipose and insulin biology to body fat distribution
The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature · doi:10.1038/nature14132 · Cited by 1,580 · cited 1×
“[15] For waist circumference, hip circumference, and waist- to- hip ratio genome- wide association studies (GWASs), the participants were 210,088 Europeans and the researchers adjusted for age, age square, and study- specific covariates if necessary.[16] In our MR analysis, we included GWASs adjusting for BMI and not…”
BackgroundSelf-citationEpidemiology of Gallbladder Disease: Cholelithiasis and Cancer
Stinton, L. M., & Shaffer, E. A. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.172 · Cited by 1,381
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Mahajan, A., Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium, Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2897 · Cited by 1,034
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Lammert, F., Gurusamy, K., Ko, C. W., Miquel, J.-F., Méndez-Sánchez, N., Portincasa, P., van Erpecum, K. J., van Laarhoven, C. J., & Wang, D. Q.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.24 · Cited by 822
The trans-ancestral genomic architecture of glycemic traits
Chen, J., Spracklen, C. N., Marenne, G., Varshney, A., Corbin, L. J., Luan, J., Willems, S. M., Wu, Y., Zhang, X., Horikoshi, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00852-9 · Cited by 793
Self-citationRole of leptin and adiponectin in insulin resistance
Yadav, A., Kataria, M. A., Saini, V., & Yadav, A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.007 · Cited by 637
Di Ciaula, A., Garruti, G., Lunardi Baccetto, R., Molina-Molina, E., Bonfrate, L., Wang, D. Q.-H., & Portincasa, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5493 · Cited by 569
Dastani, Z., Hivert, M.-F., Timpson, N., Perry, J. R. B., Yuan, X., Scott, R. A., Henneman, P., Heid, I. M., Kizer, J. R., Lyytikäinen, L.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002607 · Cited by 494
An update on the pathogenesis of cholesterol gallstone disease
Di Ciaula, A., Wang, D. Q.-H., & Portincasa, P. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000423 · Cited by 291
New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk
Lu, Y., Day, F. R., Gustafsson, S., Buchkovich, M. L., Na, J., Bataille, V., Cousminer, D. L., Dastani, Z., Drong, A. W., Esko, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10495 · Cited by 289
Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome
Wang, H. H., Lee, D. K., Liu, M., Portincasa, P., & Wang, D. Q.-H. (2020) · Pediatric Gastroenterology, Hepatology & Nutrition · doi:10.5223/pghn.2020.23.3.189 · Cited by 281
Factors associated with gallstone disease in the MICOL experience
Attili, A. F., Capocaccia, R., Carulli, N., Festi, D., Roda, E., Barbara, L., Capocaccia, L., Menotti, A., Okolicsanyi, L., Ricci, G., et al. (1997) · Hepatology · doi:10.1002/hep.510260401 · Cited by 201
The Role of Diet in the Pathogenesis of Cholesterol Gallstones
Di Ciaula, A., Garruti, G., Frühbeck, G., De Angelis, M., de Bari, O., Wang, D. Q.-H., Lammert, F., & Portincasa, P. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170530080636 · Cited by 196
Association of diabetes, serum insulin, and c-peptide with gallbladder disease
Ruhl, C. E., & Everhart, J. E. (2000) · Hepatology · doi:10.1002/hep.510310206 · Cited by 195
Contributions of Obesity and Weight Loss to Gallstone Disease
Everhart, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00010 · Cited by 189
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels
Kilpeläinen, T. O., Carli, J. F. M., Skowronski, A. A., Sun, Q., Kriebel, J., Feitosa, M. F., Hedman, Å. K., Drong, A. W., Hayes, J. E., Zhao, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10494 · Cited by 182
Yuan, S., Gill, D., Giovannucci, E. L., & Larsson, S. C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.034 · Cited by 177
Stender, S., Nordestgaard, B. G., & Tybjaerg-Hansen, A. (2013) · Hepatology · doi:10.1002/hep.26563 · Cited by 153
Shabanzadeh, D. M., Sørensen, L. T., & Jørgensen, T. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1182583 · Cited by 141
Sex and ethnic/racial-specific risk factors for gallbladder disease
Figueiredo, J. C., Haiman, C. A., Porcel, J., Buxbaum, J. L., Stram, D. O., Tambe, N. A., Cozen, W., Wilkens, L. R., Marchand, L. L., & Setiawan, V. W. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0678-6 · Cited by 130
Pathophysiological connections between gallstone disease, insulin resistance, and obesity
Cortés, V., Francisco Barrera, M., & Nervi, F. O. (2019) · Obesity Reviews · doi:10.1111/obr.12983 · Cited by 126
Triglycerides and gallstone formation
Smelt, A. H. M. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.003 · Cited by 124
Torgerson, J., Lindroos, A. K., Näslund, I., & Peltonen, M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07429.x · Cited by 117
Aune, D., & VATTEN, L. J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.012 · Cited by 117
Jaruvongvanich, V., Sanguankeo, A., & Upala, S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4125-2 · Cited by 76
Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention
Ciaula, A. D., Wang, D. Q. ‐., & Portincasa, P. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1549988 · Cited by 61
Arrese, M. A., Cortés, V., Francisco Barrera, M., & Nervi, F. O. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000416 · Cited by 56
Screen-detected gallstone disease and cardiovascular disease
Shabanzadeh, D. M., Skaaby, T., Sørensen, L. T., & Jørgensen, T. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0263-x · Cited by 47
Cha, B. H., Jang, M., & Lee, S. H. (2019) · Gut and Liver · doi:10.5009/gnl18278 · Cited by 42
Stender, S., Frikke‐Schmidt, R., Benn, M., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.013 · Cited by 33
Serum adiponectin levels in cholesterol and pigment cholelithiasis
Wang, S.-N., Yeh, Y.-T., Yu, M., Wang, C.-L., & Lee, K.-T. (2006) · British journal of surgery · doi:10.1002/bjs.5395 · Cited by 29
Méndez‐Sánchez, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i39.6182 · Cited by 27
Leptin Influence Cholelithiasis Formation by Regulating Bile Acid Metabolism
Wen, J., Yu, J., Lei, Z.-M., He, J., Ye, M., & Fu, W. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.19594 · Cited by 24
Association between metabolic syndrome and incidence of cholelithiasis in the Korean population
Kim, Y., Oh, C., Ha, E., Park, S. K., Jung, J. Y., & Ryoo, J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15568 · Cited by 22
Lack of adiponectin promotes formation of cholesterol gallstones in mice
Ogiyama, H., Kamada, Y., Kiso, S., Araki, H., Yamada, T., Nishihara, T., Watabe, K., Tochino, Y., Kihara, S., Funahashi, T., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.075 · Cited by 19
Absence of association between gallstone and coronary artery calcification
Kwon, C. H., Kang, J. G., Lee, H., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.035 · Cited by 10
Metadata
- Authors
- Chen, L., Yang, H., Li, H., He, C., Yang, L., & Lv, G.
- Venue
- Hepatology
- Published
- 2021-12-13
- Volume
- 75
- Issue
- 4
- Pages
- 785-796
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3202382702
- Cited by
- 288
- References
- 44
- FWCI
- 28.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.